Elaspeg 3750 IU Injection 1's

Elaspeg 3750 IU Injection 1's is used in the treatment of acute lymphoblastic leukaemia (ALL). It is also used with other chemotherapy drugs to treat a certain type of ALL in people who have had allergic reactions to medications similar to pegaspargase, such as asparaginase.

Elaspeg 3750 IU Injection 1's contains Pegaspargase, an enzyme that breaks down asparagine, an important building block of proteins without which cells cannot survive. Elaspeg 3750 IU Injection 1's lowers the asparagine levels in blood cancer cells and stops the cancer cells from growing.

In some cases, Elaspeg 3750 IU Injection 1's may cause side effects such as tiredness, dizziness, fever, nausea, vomiting, and diarrhoea. Most of these side effects may not require medical attention and resolve gradually over time. Do not be reluctant to talk with the doctor if any of the side effects persist or worsen.

Do not receive Elaspeg 3750 IU Injection 1's if you are pregnant or breastfeeding. Avoid driving or using machines as Elaspeg 3750 IU Injection 1's may cause drowsiness, tiredness, and confusion. Keep the doctor informed about your health condition and medications to rule out any side effects/interactions.

Elaspeg 3750 IU Injection 1's is used in the treatment of Acute Lymphoblastic Leukaemia (ALL). The detailed use of Elaspeg 3750 IU Injection 1's is as follows:

• Treatment of Acute Lymphoblastic Leukaemia (ALL): Elaspeg 3750 IU Injection 1's is used to treat acute lymphoblastic leukemia (ALL) by depleting asparagine, a crucial amino acid for cancer cell growth, ultimately killing or stopping the growth of these cells.

• Follow your doctor's instructions on the dosage and timing of this medication.
• Elaspeg 3750 IU Injection 1's will be administered by a healthcare professional.
• Do not self-administer it.

Elaspeg 3750 IU Injection 1's is used to treat acute lymphoblastic leukaemia (ALL). It is also used with other chemotherapy drugs to treat a certain type of ALL in people who have had allergic reactions to medications similar to pegaspargase, such as asparaginase. Elaspeg 3750 IU Injection 1's contains Pegaspargase, an enzyme that breaks down asparagine, an important building block of proteins without which cells cannot survive. Normal cells can make asparagine for themselves, while some cancer cells cannot. Elaspeg 3750 IU Injection 1's lowers asparagine levels in blood cancer cells and stops the cancer cells from growing.

Do not use Elaspeg 3750 IU Injection 1's if you are allergic to any of its components if you have severe liver disease, pancreatitis (inflammation of the pancreas) or if you have ever had severe bleeding or blood clots following asparaginase therapy. Inform the doctor if you have had serious allergic reactions to other forms of asparaginase, if you suffer from a bleeding disorder or have had serious blood clots, if you get a fever if you have poor liver function, diabetes, stroke or abdominal pain. Seek medical attention if you experience symptoms of osteonecrosis (pain in the knee, back or hip), liver or pancreas problems (loss of appetite, upper stomach pain, nausea or vomiting, fast heart rate, dark urine, or yellowing of the skin or eyes), low blood cell count (fever, mouth sores, skin sores, sore throat, cough, trouble breathing), blood clot (sudden numbness or weakness, problems with vision or speech, swelling or redness in an arm or leg), high blood sugar (increased thirst, increased urination, dry mouth, fruity breath odour) or if you notice unusual bleeding, easy bruising, or purple/red spot under the skin.